Xcout Intel
AcelRx Pharmaceuticals competitors & alternatives
The 12 closest competitors and alternatives to AcelRx Pharmaceuticals among pharmaceuticals companies — ranked by similarity to what AcelRx Pharmaceuticals actually does, not by market-cap band.
Subscribe to see AcelRx Pharmaceuticals’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About AcelRx Pharmaceuticals
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company based in San Mateo and Redwood City, California, focused on developing and commercializing therapeutic products.
AcelRx Pharmaceuticals at a glance
AcelRx Pharmaceuticals is a pharmaceuticals company headquartered in United States. It has raised at least $20.7M across the 4 funding rounds on record. Its most recent funding round, Seed, raised $4.9M in April 2025. Xcout tracks 11 named people at AcelRx Pharmaceuticals, including Vincent J. Angotti (Chief Executive Officer).
AcelRx Pharmaceuticals leadership
- Vincent J. AngottiChief Executive Officer
- Raffi AsadorianChief Financial Officer
- Badri DasuChief Engineering Officer
- Shakil AslamChief Medical Officer
- Adrian AdamsChairman of the Board of Directors
- Jill BroadfootDirector
5 more named people on record for AcelRx Pharmaceuticals, with roles, board committees and tenure — see the full roster →
AcelRx Pharmaceuticals funding rounds
At least $20.7M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $4.9M | — | |
| SEC Form D filing | $10M | — | |
| SEC Form D filing | $629,958 | — | |
| SEC Form D filing | $5.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 AcelRx Pharmaceuticals competitors
Ranked by semantic similarity — how close each company is to AcelRx Pharmaceuticals by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Egalet Corporation is a fully integrated specialty pharmaceutical company headquartered in Pennsylvania focused on developing, manufacturing, and commercializing treatments.
Similar pharmaceuticals company
Epalex Corp. is a clinical-stage pharmaceutical company focused on developing breakthrough therapies for migraine and epilepsy, with its corporate headquarters in Mountain View, California.
Similar pharmaceuticals company
Aradigm Corp is a specialty pharmaceutical company headquartered in Hayward, California, focused on the development and manufacturing of innovative drug delivery technologies.
Similar pharmaceuticals company
Azurity Pharmaceuticals is a U.S.-based specialty pharmaceutical company that develops and commercializes medicines for underserved patient populations, including treatments for rare diseases and complex conditions. It focuses on patient-friendly dosage forms and serves healthcare providers, patients, and caregivers, including pediatric and other populations with unmet medication needs.
Similar pharmaceuticals company
Solaris Pharma Corporation is a specialty pharmaceutical company founded in 2014 and located in Bridgewater, New Jersey.
Pharmaceuticals (Drug Delivery)
Camurus is an international pharmaceutical company that develops and provides innovative, long-acting treatments for patients with severe and chronic conditions. The company focuses on therapeutic areas including the central nervous system, rare diseases, endocrinology, oncology, and supportive care.
Similar pharmaceuticals company
Braeburn Inc. is a pharmaceutical company that develops, manufactures, and commercializes medications for central nervous system disorders, with a primary focus on delivering solutions for opioid addiction and use disorder.
Similar pharmaceuticals company
Orexo AB is a pharmaceutical company that specializes in developing innovative drug delivery technologies, notably its powder-based AmorphOX platform. The company advances proprietary and partnered pharmaceutical products, including treatments, vaccines, and nasal delivery formulations, serving patients and healthcare partners globally.
Similar pharmaceuticals company
Scilex Holding Company operates as a biopharmaceutical firm primarily engaged in creating and distributing non-opioid treatments for individuals suffering from acute and chronic pain conditions. Its flagship product, ZTlido 1.8%, is a prescription-only topical lidocaine formulation designed to alleviate neuropathic pain, specifically that associated with post-herpetic neuralgia, a type of nerve pain occurring after a shingles infection. The company's development pipeline also features SP-102, known as SEMDEXA, a viscous corticosteroid gel administered via epidural injections. This candidate is currently in Phase 3 clinical trials, targeting lumbosacral radicular pain. Another investigational drug, SP-103, aims to treat low back pain and is progressing through Phase 2 clinical trials. Additionally, SP-104, an innovative low-dose, delayed-release naltrexone hydrochloride formulation, is in Phase 1 clinical development for managing fibromyalgia. Scilex Holding Company is headquartered in Palo Alto, California, and functions as a subsidiary of Sorrento Therapeutics, Inc.
Similar pharmaceuticals company
Endo, Inc. is a Pennsylvania-based company incorporated as a Delaware corporation that operates pharmaceutical businesses, including Endo Pharmaceuticals, with executive offices located in Pennsylvania.
Similar pharmaceuticals company
Mitsubishi Tanabe Pharma America is a research-based pharmaceutical company that delivers specialty medical treatments and health solutions in the United States. Headquartered in Jersey City, New Jersey, the privately held firm operates as part of a wider global pharmaceutical heritage.
Similar pharmaceuticals company
AVEO Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing medicines for cancer and other serious diseases. It is best known for FOTIVDA (tivozanib), an oral VEGFR tyrosine kinase inhibitor approved in the United States for adults with relapsed or refractory advanced renal cell carcinoma after at least two prior systemic therapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of AcelRx Pharmaceuticals and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for AcelRx Pharmaceuticalsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →